English | Spanish
ecancer
Login Register
The content on this site is intended for healthcare professionals only

For the latest ecancer COVID-19 resources, click on this link

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Conferences
  • About us
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
+ -
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [265]
News [1742]
Articles [54]
Editorials [3]
Conferences [47]
elearning [10]
Dynamic cells linked to brain tumour growth and recurrence
Dynamic cells linked to brain tumour growth and recurrence
New fluorophores could help fight cancer
New fluorophores could help fight cancer
Study shows why many cancer cells need to import fat
Study shows why many cancer cells need to import fat
Researchers identify cryptic vulnerabilities in an oncoprotein that could be used in the development of novel anti-cancer drugs
Researchers identify cryptic vulnerabilities in an oncoprotein that could be used in the development...
New biomarkers unlock potential for more effective treatment of deadly cancers
New biomarkers unlock potential for more effective treatment of deadly cancers
Cancer patients receiving immunotherapy: No evidence of increased risk for severe immune complication after COVID-19 vaccination
Cancer patients receiving immunotherapy: No evidence of increased risk for severe immune complicatio...
ASCO 2022: Gut microbiome signatures associated with immunotherapy response in glioblastoma
ASCO 2022: Gut microbiome signatures associated with immunotherapy response in glioblastoma
Tumour ‘signatures’ could provide key to more accurate treatment for deadliest cancers
Tumour ‘signatures’ could provide key to more accurate treatment for deadliest cancers
Molecule that combines three distinct technologies against most aggressive type of brain cancer is tested
Molecule that combines three distinct technologies against most aggressive type of brain cancer is t...
EHA 2022: Dysregulation of RNA binding proteins drive hematopoietic stem cell exhaustion and bone marrow failure
EHA 2022: Dysregulation of RNA binding proteins drive hematopoietic stem cell exhaustion and bone ma...
<12345...175>

More from ecancer

Stay up to date with our ecancer newsletter

Learn more

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

Learn more

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Privacy Policy
  • Follow ecancer on Facebook
  • Follow ecancer on Twitter
  • Follow ecancer on Linkedin
  • Subscribe to the ecancer YouTube channel
© 2022 ecancer, all rights reserved
UK registered charity number: 1176307